M28 Capital Management LP

STAMFORD, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$36.0M2026 Q3
Positions9
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

M28 Capital Management LP reported 9 positions worth $36.0M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: WVE (47.1%). Biggest move: exit 96663EUR ($26.7M).

9 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 WVEWave Life Sciences$17.0M47.10%4,588,284——-15.4%
▸ 2 IVVDInvivyd$8.0M22.33%9,248,250——-33.1%
▸ 3 TGTXTG Therapeutics$4.9M13.67%88,354——+15.7%
▸ 4 ARWRArrowhead Pharmaceuticals$2.4M6.69%36,851——-32.5%
▸ 5 SLNSilence Therapeutics$1.1M3.07%101,203———
▸ 6Fractyl HealthFractyl Health$1.0M2.80%1,856,117———
▸ 7 PRQRProQR Therapeutics N.V.$995.7K2.76%599,793——-16.3%
▸ 8 RCKTRocket Pharmaceuticals$554.6K1.54%210,871——-17.9%
▸ 9 CRISCuris$12.0K0.03%14,244———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does M28 Capital Management LP hold as of Q3 2026?

M28 Capital Management LP reported 9 positions worth $36.0M in its Q3 2026 13F filing. Largest positions: WVE (47.1%), IVVD (22.3%), TGTX (13.7%), ARWR (6.7%) and SLN (3.1%).

What did M28 Capital Management LP buy in Q3 2026?

New positions: WVE and CRIS.

What did M28 Capital Management LP sell in Q3 2026?

Sold out entirely: 96663EUR and CRIS1EUR.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.